Company Overview

Development Stage

About the Company

[Summary] 致力于研发并商业化更安全、更有效的创新型疫苗

江苏瑞科生物技术股份有限公司(“瑞科生物”,股票代码02179.HK)始创于2012年,是一家以自主研发技术为核心驱动力的创新型疫苗公司。公司始终秉持“创制一流疫苗,守护人类健康”的使命,通过战略性聚焦重大传染性疾病负担,构建自主知识产权重磅疫苗产品管线组合,以应对远未满足的公共卫生需求。
历经二十余年技术积淀,瑞科生物已搭建新型佐剂、蛋白工程、免疫评价和工艺开发四大创新平台。公司是全球少数几家有能力研制及生产全系列新型佐剂的公司之一。公司四大平台密切协同,能够持续开发性能领先的重磅疫苗品种。
在强大创新平台的驱动下,公司已构建包含10余款重磅品种的高价值创新疫苗管线组合,覆盖宫颈癌、带状疱疹、呼吸道合胞病毒、巨细胞病毒、单纯疱疹病毒感染等重大疾病领域,产品开发及临床进度*。十年磨剑,厚积薄发,瑞科生物即将进入产品商业化的爆发期。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

瑞科生物 Financing History (1 rounds)

Manage
C轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 10亿人民币
  • Investor: 淡马锡Temasek,清池...

瑞科生物 How Fast Is Hiring Growing? (19 open positions)

Manage
Note: How fast is hiring at 江苏瑞科生物技术股份有限公司 growing? 瑞科生物2026: 40 openings (down 62%), 2025: 105 openings (down 10%), 2024: 117 openings (up 14%), 2023: 103 openings (up 186%), 2022: 36 openings (down 64%), 2021: 101 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

瑞科生物 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 380%
  • 2024: Down 55%
  • 2023: Up 175%
  • 2022: Down 20%
瑞科生物 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 江苏瑞科生物技术股份有限公司 growing? 瑞科生物Master's recruitment over the years: 2025: 24 openings (up 380%), 2024: 5 openings (down 55%), 2023: 11 openings (up 175%), 2022: 4 openings (down 20%), 2021: 5 openings.

瑞科生物 Doctoral Degree Job Demand Analysis

(More)
-83%
Growth Rate
2026 vs 2025
  • 2025: Up 380%
  • 2024: Up 400%
瑞科生物 Doctoral Hiring by Year: 2026 — 20 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 江苏瑞科生物技术股份有限公司 growing? 瑞科生物Doctorate recruitment over the years: 2026: 4 openings (down 83%), 2025: 24 openings (up 380%), 2024: 5 openings (up 400%), 2023: 1 openings.

瑞科生物 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 江苏瑞科生物技术股份有限公司? Based on an analysis of 瑞科生物's job postings over the past year, "其他(研发和技术类)" demand: 24.6%, "生物/制药/化工/环保类": 24.6%, "科研类": 19.7%, "计算机/网络/技术类": 19.7%, "医疗卫生/美容保健类": 9.8%, "机械/仪器仪表类": 3.3%. For reference only.

瑞科生物 — What Are the Salaries Like? (61 records)

Manage
瑞科生物 Salary Overview
salary range: 6K - 50K, 73.9% of roles pay ¥10-50K
Note: salary statistics are based on 61 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 江苏瑞科生物技术股份有限公司?瑞科生物73.9% of positions earn 10-50K, Fresh graduate salary: ¥。Taizhou salary ranking top 5,生物/制药/化工/环保类 average salary ¥22.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 瑞科生物

(More)
Are salaries high at 江苏瑞科生物技术股份有限公司? We provide: 研究员,产品经理,检验,bp,分析,市场,注册经理,海外营销,bd,创新工程师,副总,医学经理,检测,管培生,结构设计,运维,hr,qa,产品开发,仓储. Click to view detailed salary analysis by job.

瑞科生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

瑞科生物 Related Industry Tags

Job Category

  • 生物/制药/化工/环保类
    32.5% of total 32.5%
  • 其他(研发和技术类)
    24.1% of total 24.1%
  • 科研类
    20.5% of total 20.5%
  • 计算机/网络/技术类
    20.5% of total 20.5%

Education

  • 本科
    31.3% of total 31.3%
  • 硕士
    27.7% of total 27.7%
  • 博士
    25.3% of total 25.3%
  • 大专
    8.4% of total 8.4%

Experience

  • 不限
    28.9% of total 28.9%
  • 3-5年
    27.7% of total 27.7%
  • 1-3年
    22.9% of total 22.9%
  • 5-10年
    14.5% of total 14.5%
View Detailed Analysis

What does 江苏瑞科生物技术股份有限公司 require? Who is 瑞科生物 hiring? 瑞科生物 recruitment: 生物/制药/化工/环保类占比最多占32.5%,其次是其他(研发和技术类)占24.1%. What education can get in at 瑞科生物? 本科占比最多占31.3%,其次是硕士占27.7%. High education required at 瑞科生物? 硕士占27.7%,博士占25.3%. Work experience required at 瑞科生物? 不限占比最多占28.9%,其次是3-5年占27.7%. Where are the job locations at 瑞科生物? 泰州占比最多占48.2%,其次是北京占25.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 48,296.3万(元)
Legal Representative: 刘勇
Date Established:
Credit Code: 91321291595642925C
Registered Address: 泰州市医药高新区药城大道888号

Partners & Suppliers

百因诺为其提供重组蛋白疫苗的培养基 Source
供应商 疫苗(重组蛋白)
提供生物制药设备,如层析系统、过滤系统等 Source
供应商 研发生产设备
提供生物工艺耗材、培养基等关键原材料 Source
供应商 生物试剂/耗材
提供实验室设备、试剂及耗材,用于疫苗研发与生产 Source
供应商 生物试剂/耗材
作为疫苗配送商,负责瑞科生物疫苗产品的分销与物流 Source
合作客户 分销/渠道

People who follow 瑞科生物 also follow

瑞科生物 Competitors (Similar Companies)

“疫苗研发、注册申报、产业化及销售公司”
制药/药业 医药 单抗药物 临床前研究
“Pioneering innovation, benefiting patients”
生物科技/生物工程 医药 抗体 疫苗
“Helping people live healthier and happier lives”
生产 食品包装 无菌灌装 实业投资
“Gene technology benefits humanity”
制药/药业 医药
生物科技/生物工程 营养补充剂 医疗器械 膏方
数控/CNC 触控模组 智能穿戴 可穿戴设备
生物科技/生物工程 试剂 生物试剂 抗体
DMF 干燥剂 药包材 复合材料解决方案
“专注于结构力学性能测试分析系统的研发和生产”
“Let more people benefit from the development of automotive technology”
“让原创药禧济天下”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates